Showing 421 - 440 results of 1,457 for search '"Tuberculosis"', query time: 0.07s Refine Results
  1. 421

    Implementation of an information system for tuberculosis in healthcare facilities in Indonesia: evaluation of its effectiveness and challenges by Rita Dian Pratiwi, Bachti Alisjahbana, Yanri Wijayanti Subronto, Sigit Priyanta, Suharna Suharna

    Published 2025-01-01
    “…Abstract Background Tuberculosis (TB) surveillance in Indonesia is currently supported by the recording and reporting technology Tuberculosis Information System (Sistem Informasi Tuberkulosis [SITB]). …”
    Get full text
    Article
  2. 422
  3. 423

    Assessment of Linezolid Efficacy, Safety and Tolerability in the Treatment of Tuberculosis: A Retrospective Case Review by Alena Tse-Chang, Dennis Kunimoto, Evelina Der, Rabia Ahmed

    Published 2013-01-01
    “…Linezolid is a potentially effective drug for the treatment of patients with drug-resistant tuberculosis. Among 13 patients treated for tuberculosis with linezolid in the present study, nine had treatment success and four remain on treatment. …”
    Get full text
    Article
  4. 424

    Evaluation of Task Shifting in Community-Based DOTS Program as an Effective Control Strategy for Tuberculosis by André P. Gabriel, Charles P. Mercado

    Published 2011-01-01
    “…Tuberculosis (TB) remains to be the most prevalent and debilitating pulmonary (PTB) infection in the world today, affecting about one-third of the world's population. …”
    Get full text
    Article
  5. 425
  6. 426

    Incidence of self-reported tuberculosis treatment with community-wide universal testing and treatment for HIV and tuberculosis screening in Zambia and South Africa: A planned analysis of the HPTN 071 (PopART) cluster-randomised trial. by L Telisinghe, S Floyd, D MacLeod, A Schaap, R Dunbar, J Bwalya, N Bell-Mandla, E Piwowar-Manning, D Donnell, K Shaunaube, P Bock, S Fidler, R J Hayes, H M Ayles, HPTN 071 (PopART) study team

    Published 2024-05-01
    “…<h4>Background</h4>HIV is a potent risk factor for tuberculosis (TB). Therefore, community-wide universal testing and treatment for HIV (UTT) could contribute to TB control, but evidence for this is limited. …”
    Get full text
    Article
  7. 427
  8. 428

    Surgical treatment outcomes and risk factors for post-TB lung disease by C. Guo, Q. Li, L. Wei, Y. Liu, D. Sun, C. Ding

    Published 2024-11-01
    Subjects: “…post-tuberculosis lung disease…”
    Get full text
    Article
  9. 429
  10. 430
  11. 431
  12. 432
  13. 433

    Antiretroviral Treatment-Associated Tuberculosis in a Prospective Cohort of HIV-Infected Patients Starting ART by William Worodria, Marguerite Massinga-Loembe, Harriet Mayanja-Kizza, Jane Namaganda, Andrew Kambugu, Yukari C. Manabe, Luc Kestens, Robert Colebunders

    Published 2011-01-01
    “…The subset of patients that are diagnosed with tuberculosis (TB) disease while on ART have been classified as ART-associated TB. …”
    Get full text
    Article
  14. 434

    Potential and challenges for an integrated management of tuberculosis, diabetes mellitus, and hypertension: A scoping review protocol. by Vitri Widyaningsih, Ratih Puspita Febrinasari, Victoria Sari, Clarissa Augustania, Bintang Verlita, Chatarina Wahyuni, Bachti Alisjahbana, Ailiana Santosa, Nawi Ng, Ari Probandari

    Published 2022-01-01
    “…The transmission of tuberculosis, one of the leading infectious diseases, can be halted through active screening of risk groups and early case findings. …”
    Get full text
    Article
  15. 435
  16. 436

    Study on association of nuclear factor kappa B gene polymorphism with bacterial load in pulmonary tuberculosis by Pallavi Baliarsingh, Pratima Kumari Sahu, Paresh Nath Mohanty, Roma Rattan, Monalisa Mohapatro

    Published 2023-12-01
    “…Objectives: Pulmonary tuberculosis (PTB) is a leading infectious disease and a major public health concern. …”
    Get full text
    Article
  17. 437

    Gaps in Study Design for Immune Parameter Research for Latent Tuberculosis Infection: A Systematic Review by Mariana Herrera, Cristian Vera, Yoav Keynan, Zulma Vanessa Rueda

    Published 2020-01-01
    “…Immune parameters (IP) have been extensively studied to distinguish between latent tuberculosis (LTBI) and active tuberculosis (TB). Objective. …”
    Get full text
    Article
  18. 438
  19. 439

    A Prospective Study of Tuberculosis Drug Susceptibility in Sabah, Malaysia, and an Algorithm for Management of Isoniazid Resistance by Muhammad Redzwan S. Rashid Ali, Uma Parameswaran, Timothy William, Elspeth Bird, Christopher S. Wilkes, Wai Khew Lee, Tsin Wen Yeo, Nicholas M. Anstey, Anna P. Ralph

    Published 2015-01-01
    “…Introduction. The burden of tuberculosis is high in eastern Malaysia, and rates of Mycobacterium tuberculosis drug resistance are poorly defined. …”
    Get full text
    Article
  20. 440

    A Multiregion Discrete-Time Epidemic Model of Mycobacterium tuberculosis Infections: An Optimal Control Approach by Rachid Bouajaji, Hassan Laarabi, Mostafa Rachik, Abdelhadi Abta

    Published 2021-01-01
    “…However, since both the environment and any population are spatially heterogeneous, it is obviously desirable to include spatial structure into an epidemic model. Individuals with tuberculosis can spread the disease by moving from one area to another. …”
    Get full text
    Article